Ausgabe 8/2018
Inhalt (20 Artikel)
MicroRNAs in regulation of triple-negative breast cancer progression
Dominika Piasecka, Marcin Braun, Radzislaw Kordek, Rafal Sadej, Hanna Romanska
Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial–mesenchymal transition phenotype
Jing Xu, Xiaoting Zhao, Dengfeng He, Jinghui Wang, Weiying Li, Yinghui Liu, Li Ma, Mei Jiang, Yu Teng, Ziyu Wang, Meng Gu, Jianbin Wu, Yue Wang, Wentao Yue, Shucai Zhang
Relationship between TNF-α −1031T/C gene polymorphism, plasma level of TNF-α, and risk of cachexia in head and neck cancer patients
Tomasz Powrózek, Radosław Mlak, Anna Brzozowska, Marcin Mazurek, Paweł Gołębiowski, Teresa Małecka-Massalska
Machine learning identifies a core gene set predictive of acquired resistance to EGFR tyrosine kinase inhibitor
Young Rae Kim, Sung Young Kim
TIS21/BTG2 inhibits breast cancer growth and progression by differential regulation of mTORc1 and mTORc2–AKT1–NFAT1–PHLPP2 signaling axis
Santhoshkumar Sundaramoorthy, Preethi Devanand, Min Sook Ryu, Kye Yong Song, Dong Young Noh, In Kyoung Lim
Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells
Yi-Fan Li, Hou-Ting Zhang, Lin Xin
Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model
Vivian Adamski, Christina Schmitt, Florian Ceynowa, Rainer Adelung, Ralph Lucius, Michael Synowitz, Kirsten Hattermann, Janka Held-Feindt
Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines
Jin Sun Kim, Gwang Hyeon Choi, Yusun Jung, Kang Mo Kim, Se-Jin Jang, Eun Sil Yu, Han Chu Lee
Emerging strategies in BRCA-positive pancreatic cancer
Adam Kowalewski, Łukasz Szylberg, Michał Saganek, Wojciech Napiontek, Paulina Antosik, Dariusz Grzanka
Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma
Kai Wang, Xiao Qu, Shaorui Liu, Xudong Yang, Fenglong Bie, Yu Wang, Cuicui Huang, Jiajun Du
Vaginal brachytherapy for endometrial cancer
Peter Hass, Selvi Seinsch, Holm Eggemann, Tanja Ignatov, Stephan Seitz, Atanas Ignatov
Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study
Florian Nolte, Holger Nückel, Burkhard Schmidt, Thomas Geer, Oleg Rubanov, Holger Hebart, Andrea Jarisch, Stefan Albrecht, Christiane Johr, Christiane Schumann, Wolf-Karsten Hofmann
Outcomes of Takotsubo cardiomyopathy in hospitalized cancer patients
Parijat Saurav Joy, Achuta Kumar Guddati, Iuliana Shapira
Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer
Koji Takada, Shinichiro Kashiwagi, Wataru Goto, Yuka Asano, Katsuyuki Takahashi, Tamami Morisaki, Tsutomu Takashima, Shuhei Tomita, Kosei Hirakawa, Masaichi Ohira
Patterns of platinum drug use in an acute care setting: a retrospective study
Evangeline Armstrong-Gordon, Danijela Gnjidic, Andrew J. McLachlan, Bayan Hosseini, Andrew Grant, Philip J. Beale, Nial J. Wheate
The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients
Neval E. Wareham, Amanda Mocroft, Henrik Sengeløv, Caspar Da Cunha-Bang, Finn Gustafsson, Carsten Heilmann, Martin Iversen, Nikolai S. Kirkby, Allan Rasmussen, Søren Schwartz Sørensen, Jens D. Lundgren, Michael Perch, Finn Gustafsson, Allan Rasmussen, Søren Schwartz Sørensen, Henrik Sengeløv
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial
Christina Schaub, Sied Kebir, Nina Junold, Elke Hattingen, Niklas Schäfer, Joachim P. Steinbach, Astrid Weyerbrock, Peter Hau, Roland Goldbrunner, Michael Niessen, Frederic Mack, Moritz Stuplich, Theophilos Tzaridis, Oliver Bähr, Rolf-Dieter Kortmann, Uwe Schlegel, Friederike Schmidt-Graf, Veit Rohde, Christian Braun, Mathias Hänel, Michael Sabel, Rüdiger Gerlach, Dietmar Krex, Claus Belka, Hartmut Vatter, Martin Proescholdt, Ulrich Herrlinger, Martin Glas
End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer
Yingming Zhu, Ke Tang, Fen Zhao, Yuanwei Zang, Xiaodong Wang, Zhenxiang Li, Xindong Sun, Jinming Yu
Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations
Yusuke Okuma, Jumpei Kashima, Kageaki Watanabe, Sadamu Homma
Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients
Tiina Moilanen, Anna Jokimäki, Olli Tenhunen, Jussi P. Koivunen